Table 1 Clinical features of all patients
From: SOXs in human prostate cancer: implication as progression and prognosis factors
Sample type & Clinical features | Experiment type (cases) | ||
|---|---|---|---|
Microarray | RT-QPCR | IHC | |
Prostate cancer | 4 | 10 | 147 |
Mean age (range, years) | 70.25 ± 11.6154 | 73.90 ± 10.8572 | 58.17 ± 7.038 |
(54-80) | (54-87) | (37-83) | |
 ≤60 | 1 | 2 | 99 |
 >60 | 3 | 8 | 48 |
Serum PSA levels (ng/ml) | |||
 <10 | 1 | 1 | 10 |
 ≥10 | 3 | 9 | 74 |
Gleason score | |||
 <8 | 2 | 4 | 29 |
 ≥8 | 2 | 6 | 118 |
Metstasis | 0 | 0 | 19 |
Adjacent benign prostate tissue | 4 | 10 | 28 |